| | | | | | | | | | | | | | | | | | | | | | | | | | |
Gains (losses) in net income: | | Affected line item in the Consolidated Statements of Operations: | | 2025 | | 2024 | | 2023 |
Market value adjustments, primarily cash flow hedges | | Primarily revenue | | $ | 250 | | | $ | 466 | | | $ | 444 | |
| Estimated tax | | Income taxes | | (58) | | | (108) | | | (103) | |
| | | | 192 | | | 358 | | | 341 | |
| | | | | | | | |
| | | | | | | | |
Pension and postretirement medical expense | | Interest expense, net | | (132) | | | 96 | | | (4) | |
| Estimated tax | | Income taxes | | 32 | | | (24) | | | — | |
| | | | (100) | | | 72 | | | (4) | |
| | | | | | | | |
Foreign currency translation and other | | Other income (expense), net | | — | | | — | | | (42) | |
Estimated tax | | Income taxes | | — | | | — | | | 14 | |
| | | | — | | | — | | | (28) | |
| | | | | | | | |
Total reclassifications for the period | | | | $ | 92 | | | $ | 430 | | | $ | 309 | |
